School of Finance, Harbin University of Commerce, Harbin, Heilongjiang, China.
Department of Neurology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Front Public Health. 2022 Nov 24;10:1024997. doi: 10.3389/fpubh.2022.1024997. eCollection 2022.
Pharmaceutical manufacturing industry is an important industry to ensure human life safety. The innovation efficiency is a significant factor to stimulate the development of pharmaceutical manufacturing industry. At present, there are few studies on the innovation efficiency of pharmaceutical manufacturing industry. To fill this gap, this paper estimates the innovation efficiency of China's pharmaceutical manufacturing industry in 23 provinces of China from 2010 to 2020 based on the super-network SBM model and Global-Malmquist index. The results show that: (1) From the perspective of efficiency of research and development stage (ERDS), the ERDS of China shows an increasing trend, with the most prominent growth in the western region. (2) From the perspective of efficiency of economic transformation stage (EETS), although there are fluctuations in the EETS, the overall development is good. The EETS of the central region and western region is better than that of the eastern region. (3) By comparing the efficiency of the two stages, it is found that the change direction of the efficiency of the two stages is not necessarily the same in some provinces.
制药行业是保障人类生命安全的重要产业。创新效率是刺激制药行业发展的重要因素。目前,关于制药行业创新效率的研究较少。为了填补这一空白,本文基于超网络 SBM 模型和全局 Malmquist 指数,测算了 2010 年至 2020 年中国 23 个省份的制药行业创新效率。结果表明:(1)从研发阶段效率(ERDS)来看,中国的 ERDS 呈增长趋势,西部地区增长最为显著。(2)从经济转化阶段效率(EETS)来看,尽管 EETS 存在波动,但整体发展良好。中部地区和西部地区的 EETS 优于东部地区。(3)通过比较两个阶段的效率,发现一些省份两个阶段的效率变化方向不一定相同。